Filing Flows › Clorox (CLX) › Q1 FY27 › vs Q1 FY26
Clorox (CLX) Q1 FY27 vs Q1 FY26 (year over year)
Clorox's revenue rose $476M (+33%) from $1.4B in Q1 FY26 to $1.9B in Q1 FY27. Gross margin 40.4% against 41.7% (-1.3 pts).
Clorox, Q1 FY27: revenue $1.9B (+33% year over year), operating margin 10.9%, net earnings $170M, operating cash flow $143M. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Gross margin | 40.4% | 41.7% | -1.3 pts |
| Operating margin | 10.9% | 7.5% | +3.4 pts |
| Net margin | 8.9% | 5.6% | +3.3 pts |
| Free cash flow margin | 5.5% | 4.0% | +1.5 pts |
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $1.9B | $1.4B | $476M | +33% |
| Gross profit | $770M | $596M | $174M | +29% |
| Cost of revenue | $1.1B | $833M | $302M | +36% |
| Operating profit | $207M | $107M | $100M | +93% |
| Operating expenses | $563M | $489M | $74.0M | +15% |
| Pre-tax earnings | $207M | $107M | $100M | +93% |
| Research & development | $29.0M | $28.0M | $1.0M | +4% |
| SG&A | $290M | $277M | $13.0M | +5% |
| Other operating costs | $244M | $184M | $60.0M | +33% |
| Net earnings | $170M | $80.0M | $90.0M | +112% |
| Minority interests | $3.0M | $2.0M | $1.0M | +50% |
| Income tax | $34.0M | $25.0M | $9.0M | +36% |
| Depreciation & amortization | $74.0M | $56.0M | $18.0M | +32% |
| Share-based compensation | $9.0M | $10.0M | −$1.0M | -10% |
| Working capital & other | $110M | $53.0M | $57.0M | +108% |
| Operating cash flow | $143M | $93.0M | $50.0M | +54% |
| Free cash flow (OCF − capex) | $105M | $57.0M | $48.0M | +84% |
| Capital expenditures | $38.0M | $36.0M | $2.0M | +6% |
Questions
How much did Clorox's revenue grow year over year in Q1 FY27?
Clorox's revenue rose $476M (+33%) from $1.4B in Q1 FY26 to $1.9B in Q1 FY27. Gross margin 40.4% against 41.7% (-1.3 pts).